In this issue:
- Dual therapy in refractory paediatric IBD
- Curcumin-QingDai combination for active UC
- Cumulative exposure to immunomodulators and risk of cervical neoplasia
- Early biological therapy after CD surgery
- Validation of models to differentiate intestinal tuberculosis from CD
- Ustekinumab and vedolizumab during pregnancy
- Therapeutic drug monitoring with biologics in IBD
- Vedolizumab and postoperative complications in IBD
- Science blog: faecal microbiota transplantation for IBD
Please login below to download this issue (PDF)